US Free Vaccine Plan Dropped

23 April 1995

The US government has dropped plans to distribute free vaccines to private doctors who treat poor children in 14 states, and some patients will now not get free shots until next year.

While all public clinics and private doctors in most states have participated in the Vaccines for Children program since October, 14 states had no way to get the free vaccine to private doctors. The Centers for Disease Control tried to reach agreement with vaccine makers to make deliveries, but only one deal has been worked out so far, said CDC director David Satcher; these states are now forming their own distribution plans and the government is dropping federal delivery plans. Arizona, California, Iowa, Missouri, New Jersey, Oregon, Tennessee, Utah and Virginia plan to offer private doctors the free vaccine before year-end, while Colorado, Louisiana, Nebraska and Pennsylvania will not take part till 1996.

A Merck & Co spokesman said the change means the firm has lost $100,000 invested in computer equipment to deliver to the states at cost, which is less than some other states are paying. It feels that better arrangements could have been made, and at cheaper cost to the taxpayer.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight